Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis
Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…
CertaraJuly 16, 2026
Enhancing clinical trials with real-world evidence in pregnancy research
Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…
CertaraJune 26, 2026
Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices
Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…
CertaraJune 22, 2026
QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials
QSP modeling for Parkinson’s disease tackles optimized standard-of-care, placebo response, and missing biomarkers. See how…
CertaraJune 11, 2026
Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib
This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…
Dorottya Gui-BodnarMay 28, 2026
Everything You Need to Know About CRFs in Clinical Trials
Read about the basics of CRFs and eCRF design, why annotated CRFs should be standardized…
CertaraMay 22, 2026
